A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

BACKGROUND: Posaconazole (POS) is a potent triazole antifungal agent approved in adults for treatment and prophylaxis of invasive fungal infections (IFIs). The objectives of this study were to evaluate the pharmacokinetics (PK), safety, and tolerability of POS oral suspension in pediatric subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Antonio C., Sung, Lillian, Bradley, John S., Zwaan, C. Michel, Gates, Davis, Waskin, Hetty, Carmelitano, Patricia, Groll, Andreas H., Lehrnbecher, Thomas, Mangin, Eric, Joshi, Amita, Kartsonis, Nicholas A., Walsh, Thomas J., Paschke, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435162/
https://www.ncbi.nlm.nih.gov/pubmed/30913226
http://dx.doi.org/10.1371/journal.pone.0212837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435162/
https://www.ncbi.nlm.nih.gov/pubmed/30913226
http://dx.doi.org/10.1371/journal.pone.0212837

Ejemplares similares